This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2001 Jun;27(4):335-7.

doi: 10.1053/ejso.2000.1078.

Does c-erbB2/HER2 overexpression predict adjuvant tamoxifen failure in patients with early breast cancer?

J C Hu¹, K Mokbel

Affiliations

PMID: 11417974
DOI: 10.1053/ejso.2000.1078

Does c-erbB2/HER2 overexpression predict adjuvant tamoxifen failure in patients with early breast cancer?

J C Hu et al. Eur J Surg Oncol. 2001 Jun.

. 2001 Jun;27(4):335-7.

doi: 10.1053/ejso.2000.1078.

Authors

J C Hu¹, K Mokbel

Affiliation

¹ The Breast Unit, St George's Hospital, Blackshaw Road, London SW17 0QT, UK.

PMID: 11417974
DOI: 10.1053/ejso.2000.1078

No abstract available

Similar articles

Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
Holm C, Rayala S, Jirström K, Stål O, Kumar R, Landberg G. Holm C, et al. J Natl Cancer Inst. 2006 May 17;98(10):671-80. doi: 10.1093/jnci/djj185. J Natl Cancer Inst. 2006. PMID: 16705121
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, Cronin M, Walker M, Watson D, Shak S, Hortobagyi GN. Esteva FJ, et al. Clin Cancer Res. 2005 May 1;11(9):3315-9. doi: 10.1158/1078-0432.CCR-04-1707. Clin Cancer Res. 2005. PMID: 15867229
A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA. Vendrell JA, et al. Breast Cancer Res. 2008;10(5):R88. doi: 10.1186/bcr2158. Epub 2008 Oct 17. Breast Cancer Res. 2008. PMID: 18928543 Free PMC article.
The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women.
Mouridsen HT, Robert NJ. Mouridsen HT, et al. Eur J Cancer. 2005 Aug;41(12):1678-89. doi: 10.1016/j.ejca.2004.10.020. Epub 2004 Nov 25. Eur J Cancer. 2005. PMID: 16098456 Review.
The nature of tamoxifen action in the control of female breast cancer.
Kodama M, Kodama T. Kodama M, et al. In Vivo. 2001 Jul-Aug;15(4):319-25. In Vivo. 2001. PMID: 11695224 Review.

See all similar articles

Cited by

Human epidermal growth factor receptor-2 and endocrine resistance in hormone-dependent breast cancer.
Alataki A, Dowsett M. Alataki A, et al. Endocr Relat Cancer. 2022 Jun 23;29(8):R105-R122. doi: 10.1530/ERC-21-0293. Print 2022 Aug 1. Endocr Relat Cancer. 2022. PMID: 35613334 Free PMC article. Review.
Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.
Ghosh D, Lo J, Egbuta C. Ghosh D, et al. J Med Chem. 2016 Jun 9;59(11):5131-48. doi: 10.1021/acs.jmedchem.5b01281. Epub 2016 Jan 19. J Med Chem. 2016. PMID: 26689671 Free PMC article. Review.
Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex.
Giessrigl B, Schmidt WM, Kalipciyan M, Jeitler M, Bilban M, Gollinger M, Krieger S, Jäger W, Mader RM, Krupitza G. Giessrigl B, et al. Br J Cancer. 2013 Nov 12;109(10):2751-62. doi: 10.1038/bjc.2013.583. Epub 2013 Oct 29. Br J Cancer. 2013. PMID: 24169358 Free PMC article.
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.
Thangavel C, Dean JL, Ertel A, Knudsen KE, Aldaz CM, Witkiewicz AK, Clarke R, Knudsen ES. Thangavel C, et al. Endocr Relat Cancer. 2011 Apr 28;18(3):333-45. doi: 10.1530/ERC-10-0262. Print 2011 Jun. Endocr Relat Cancer. 2011. PMID: 21367843 Free PMC article.
The role of Herceptin in early breast cancer.
Subramanian A, Mokbel K. Subramanian A, et al. Int Semin Surg Oncol. 2008 Apr 28;5:9. doi: 10.1186/1477-7800-5-9. Int Semin Surg Oncol. 2008. PMID: 18442393 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- Genetic Alliance
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal